B
Bull
Bull · 25%GPAT
$10.98
情境價格
$11.140
0.000 (0.00%)收盤時
Loading chart…
- High
- 11.140
- Open
- 11.140
- VWAP
- 11.14
- Vol
- 3.00
- Mkt Cap
- —
- Low
- 11.140
- Amount
- 33.42
- EV/EBITDA, TTM
- 0.00
GP-Act III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has neither engaged in any operations nor generated any revenues.
AI analysis of GP-Act III Acquisition Corp (GPAT)
sellCurrently, GP-Act III Acquisition Corp. is not a good buy. The stock's current price is 10.95, and it has a relatively low RSI of 45.589, indicating it is neither overbought nor oversold. However, the forward P/E ratio is 0, suggesting that the company is not expected to generate earnings in the near future, which is a significant concern for long-term investors. Additionally, the net income has decreased significantly to 290,121 in Q2 2026 from 3,656,457 in Q3 2024, indicating declining profitability. The main risk is the current ratio of 0.05, which shows that the company may struggle to meet its short-term liabilities.
估值指標
The current forward P/E ratio for GP-Act III Acquisition Corp (GPAT) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for GPAT
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding GPAT
GPAT FAQ — answered by Alphio AI
GP-Act III Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has neither engaged in any operations nor generated any revenues. It operates in the Financials sector.
Currently, GP-Act III Acquisition Corp. is not a good buy. The stock's current price is 10.95, and it has a relatively low RSI of 45.589, indicating it is neither overbought nor oversold. However, the forward P/E ratio is 0, suggesting that the company is not expected to generate earnings in the near future, which is a significant concern for long-term investors. Additionally, the net income has decreased significantly to 290,121 in Q2 2026 from 3,656,457 in Q3 2024, indicating declining profitability. The main risk is the current ratio of 0.05, which shows that the company may struggle to meet its short-term liabilities.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。